TEVA PHARMACEUTICAL INDUSTRIES LIMITED Empresa Teva Pharmaceutical Industries Limited TEL AVIV STOCK EXCHANGE
Acciones
IL0006290147
Farmacéuticos
Resumen de negocios
Ventas por actividad
| USD en millones | 2022 | Peso | 2023 | Peso | Delta |
|---|---|---|---|---|---|
Generics, Innovative Medicines and Over-the-counter Products
100,0
%
| 14 925 | 100,0 % | 15 846 | 100,0 % | +6,17 % |
Ventas por región
| USD en millones | 2022 | Peso | 2023 | Peso | Delta |
|---|---|---|---|---|---|
North America
51,3
%
| 7 452 | 49,9 % | 8 124 | 51,3 % | +9,02 % |
Europe
30,5
%
| 4 525 | 30,3 % | 4 837 | 30,5 % | +6,90 % |
International
12,4
%
| 1 903 | 12,8 % | 1 958 | 12,4 % | +2,89 % |
Global
5,8
%
| 1 045 | 7,0 % | 926 | 5,8 % | -11,39 % |
Directores
| Directores | Puesto | Edad | Desde |
|---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 55 | 01/01/23 |
Eli Kalif
DFI | Director of Finance/CFO | 51 | 22/12/19 |
Kathleen Veit
CMP | Compliance Officer | - | 01/01/10 |
Eric Hughes
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/22 |
Amir Elstein
BRD | Director/Board Member | 67 | 01/01/95 |
Yael Ashman
IRO | Public Communications Contact | - | 01/09/09 |
Ran Meir
IRC | Investor Relations Contact | - | - |
Vikki Conway
HRO | Human Resources Officer | - | 01/01/10 |
Amir Weiss
AUD | Comptroller/Controller/Auditor | 47 | 01/06/12 |
Dov Bergwerk
SEC | Corporate Secretary | - | - |
Administradores
| Administradores | Puesto | Edad | Desde |
|---|---|---|---|
Gerald Lieberman
BRD | Director/Board Member | 77 | 01/09/15 |
Janet Vergis
BRD | Director/Board Member | 59 | 09/06/20 |
Sol Barer
CHM | Chairman | 76 | 01/01/15 |
Roberto Mignone
BRD | Director/Board Member | 52 | 14/07/17 |
Amir Elstein
BRD | Director/Board Member | 67 | 01/01/95 |
Rosemary Crane
BRD | Director/Board Member | 64 | 01/09/15 |
Richard Francis
CEO | Chief Executive Officer | 55 | 01/01/23 |
Perry Nisen
BRD | Director/Board Member | 68 | 14/07/17 |
Tal Zaks
BRD | Director/Board Member | 58 | 01/10/21 |
| Director/Board Member | 52 | 01/06/18 |
Clase de acciones
| Vote | Quantity | Flotante | Autocontrol | Total Float | |
|---|---|---|---|---|---|
| Acción A | 1 | 1 238 592 397 | 1 126 216 605 ( 90,93 %) | 106 000 000 ( 8,558 %) | 90,93 % |
Información de la empresa
Teva Pharmaceutical Industries Ltd.
124 Dvora HaNevi'a Street
6944020, Tel Aviv
+972 3 914 8213
http://www.tevapharm.com
Empresas del grupo
| Nombre | Categoría y sector |
|---|---|
Teva Czech Industries sro
 Teva Czech Industries sro Pharmaceuticals: MajorHealth Technology Part of Teva Pharmaceutical Industries Ltd., Teva Czech Industries sro develops drugs for pharmaceutical preparation. The company is based in Opava, Czechia. Jiri Urbanec has been the CEO of the Czech company since 2006. |
Pharmaceuticals: Major
|
Actavis Pharma Development Centre Pvt Ltd.
 Actavis Pharma Development Centre Pvt Ltd. Pharmaceuticals: GenericHealth Technology Founded in 2006, Actavis Pharma Development Centre Pvt Ltd. is a subsidiary of AbbVie, Inc. that develops, manufactures, and sells generic pharmaceutical products. The company is based in Mumbai, India. |
Pharmaceuticals: Generic
|
Teva Pharmaceutical Finance IV BV
|
Finance/Rental/Leasing
|
Teva Finance Services BV
 Teva Finance Services BV Finance/Rental/LeasingFinance Part of Teva Pharmaceutical Industries Ltd., Teva Finance Services BV is a Dutch company that provides finance services. The company is located in the Netherlands. |
Finance/Rental/Leasing
|
Teva Finance Services II BV
 Teva Finance Services II BV Finance/Rental/LeasingFinance Part of Teva Pharmaceutical Industries Ltd., Teva Finance Services II BV is a Dutch company that provides finance services. The company is located in the Netherlands. |
Finance/Rental/Leasing
|
Teva Pharmaceutical Finance Netherlands II BV
|
Finance/Rental/Leasing
|
Teva Pharmaceutical Finance Netherlands IV BV
|
Finance/Rental/Leasing
|
Teva Pharmaceutical Finance Netherlands III BV
|
Finance/Rental/Leasing
|
Actavis Holding Asia BV
 Actavis Holding Asia BV MiscellaneousMiscellaneous Part of AbbVie, Inc., Actavis Holding Asia holding company. The company is based in Haarlem, the Netherlands. |
Miscellaneous
|
Ventas por región
| Varia. 1 de ene. | Capi. | |
|---|---|---|
| +55,05 % | 811 mil M | |
| +43,62 % | 640 mil M | |
| -7,13 % | 353 mil M | |
| +17,93 % | 333 mil M | |
| +8,38 % | 302 mil M | |
| +16,30 % | 246 mil M | |
| +2,41 % | 225 mil M | |
| +12,47 % | 218 mil M | |
| +8,63 % | 168 mil M |
